We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Local pharmaceutical firms and market observers are increasingly
questioning the role of government in the Polish sector, despite key regulatory
changes in recent years.
New studies conducted by international consultancy Ernst & Young and
the Confederation of Indian Industry (CII) have highlighted the growth potential
of India's pharmaceuticals sector.
Sanofi-aventis SA said about 500 employees have accepted an early-retirement
package proposed by management as part of the merger of Sanofi-Synthelabo and
Aventis last year.
Dishman Pharmaceuticals & Chemicals board has recommended the final dividend
at 25 percent on the paid-up equity share capital of the company, for the financial
year 2004-2005.
Cangen Biotechnologies announced a research collaboration with Olympus Corporation
for the development of a hybrid DNA-based and protein-based diagnostic test
for use in the detection of lung cancer.
CytoGenix announced that it has obtained a commercial evaluation license from
the National Institutes of Health (NIH) for a DNA plasmid developed by scientists
from the National Institute of Allergy and Infectious Diseases (NIAID) Vaccine
Research Center (VRC).
New international studies confirm that drug provision in South
Africa remains highly uneven, with wide disparities between wealthy urban areas
and poor rural and urban zones.